- Home
- BH vs RAPP Comparison
BH vs RAPP Comparison
Compare BH & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- RAPP
- Stock Information
- Founded
- BH 1934
- RAPP 2022
- Country
- BH United States
- RAPP United States
- Employees
- BH N/A
- RAPP N/A
- Industry
- BH Restaurants
- RAPP
- Sector
- BH Consumer Discretionary
- RAPP
- Exchange
- BH Nasdaq
- RAPP Nasdaq
- Market Cap
- BH 1.2B
- RAPP 1.2B
- IPO Year
- BH N/A
- RAPP 2024
- Fundamental
- Price
- BH $360.01
- RAPP $25.66
- Analyst Decision
- BH
- RAPP Strong Buy
- Analyst Count
- BH 0
- RAPP 4
- Target Price
- BH N/A
- RAPP $46.50
- AVG Volume (30 Days)
- BH 10.9K
- RAPP 401.4K
- Earning Date
- BH 11-07-2025
- RAPP 11-06-2025
- Dividend Yield
- BH N/A
- RAPP N/A
- EPS Growth
- BH N/A
- RAPP N/A
- EPS
- BH 7.91
- RAPP N/A
- Revenue
- BH $386,507,000.00
- RAPP N/A
- Revenue This Year
- BH N/A
- RAPP N/A
- Revenue Next Year
- BH N/A
- RAPP N/A
- P/E Ratio
- BH $529.73
- RAPP N/A
- Revenue Growth
- BH 6.87
- RAPP N/A
- 52 Week Low
- BH $171.00
- RAPP $6.43
- 52 Week High
- BH $381.83
- RAPP $42.27
- Technical
- Relative Strength Index (RSI)
- BH 53.55
- RAPP 47.91
- Support Level
- BH $349.08
- RAPP $25.17
- Resistance Level
- BH $372.44
- RAPP $27.28
- Average True Range (ATR)
- BH 11.46
- RAPP 1.91
- MACD
- BH -2.52
- RAPP -0.27
- Stochastic Oscillator
- BH 30.29
- RAPP 27.82
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.